Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases
Yu-Ting Dai,Fan Zhang,Hai Fang,Jian-Feng Li,Gang Lu,Lu Jiang,Bing Chen,Dong-Dong Mao,Yuan-Fang Liu,Jin Wang,Li-Jun Peng,Chong Feng,Hai-Feng Chen,Jun-Xi Mu,Qun-Ling Zhang,Hao Wang,Hany Ariffin,Tan Ah Moy,Jing-Han Wang,Yin-Jun Lou,Su-Ning Chen,Qian Wang,Hong Liu,Zhe Shan,Itaru Matsumura,Yasushi Miyazaki,Takahiko Yasuda,Li-Ping Dou,Xiao-jing Yan,Jin-Song Yan,Allen Eng-Juh Yeoh,De-Pei Wu,Hitoshi Kiyoi,Fumihiko Hayakawa,Jie Jin,Sheng-Yue Wang,Xiao-Jian Sun,Jian-Qing Mi,Zhu Chen,Jin-Yan Huang,Sai-Juan Chen
DOI: https://doi.org/10.1073/pnas.2120787119
2022-01-01
Abstract:T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy of T cell progenitors, known to be a heterogeneous disease in pediatric and adult patients. Here we attempted to better understand the disease at the molecular level based on the transcriptomic landscape of 707 T-ALL patients (510 pediatric, 190 adult patients, and 7 with unknown age; 599 from published cohorts and 108 newly investigated). Leveraging the information of gene expression enabled us to identify 10 subtypes (G1-G10), including the previously undescribed one characterized by GATA3 mutations, with GATA3(R276Q) capable of affecting lymphocyte development in zebrafish. Through associating with T cell differentiation stages, we found that high expression of LYL1/LMO2/SPI1/HOXA (G1-G6) might represent the early T cell progenitor, pro/precortical/cortical stage with a relatively high age of disease onset, and lymphoblasts with TLX3/TLX1 high expression (G7-G8) could be blocked at the cortical/post-cortical stage, while those with high expression of NKX2-1/TAL1/LMO1 (G9-G10) might correspond to cortical/post-cortical/mature stages of T cell development. Notably, adult patients harbored more cooperative mutations among epigenetic regulators, and genes involved in JAK-STAT and RAS signaling pathways, with 44% of patients aged 40 y or above in G1 bearing DNMT3A/IDH2 mutations usually seen in acute myeloid leukemia, suggesting the nature of mixed phenotype acute leukemia.